Filing Details
- Accession Number:
- 0001209191-21-069351
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-13 20:41:12
- Reporting Period:
- 2021-12-09
- Accepted Time:
- 2021-12-13 20:41:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636282 | Aeglea Biotherapeutics Inc. | AGLE | Pharmaceutical Preparations (2834) | 464312787 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1656151 | Armen Shanafelt | C/O Aeglea Biotherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX 78746 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-09 | 121,799 | $3.67 | 121,799 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-10 | 13,516 | $3.65 | 135,315 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-13 | 14,685 | $3.65 | 150,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.53 to $3.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
Billionaire Hedge Funds
